AI Tools In Pharmaceutical Research

CELLIMA TALKS, Insights

Cellima Talks III

AI Tools in early pharmaceutical research

Join us for an exciting discussion on the use of specialized AI tools in early drug discovery.

Together with David Egan, CEO of Core Life Analytics, and Philipp Kainz, CEO of KML Vision, Stefan Prechtl discusses the use of the latest developments in the field of advanced machine learning and deep learning, which can significantly improve research efforts in early drug discovery.

In addition to all the opportunities and benefits of these modern technologies, the panelists also talk about the exaggerated expectations, exaggerated fears, and drawbacks of this modern approach.

Learn how to get the most out of your data by safely using AI tools.

This is a recording of a live-streamed event. The audience was able to ask questions in the chat during the interview, which were answered directly by the panelists.

more insights

HCI 2024 – Prospects

2024-03-12

In order to better describe the current state and future prospects of High-Content Imaging, a market survey was conducted among researchers and organizations involved in early drug discovery worldwide.

The Power of Cell Painting & AI

2024-01-05

Want to explore the groundbreaking intersection of cell biology and artificial intelligence in drug discovery? I was delighted to have the opportunity to discuss this topic with Niranj Chandrasekaran of the BROAD Institute on January 12, 2024. In this interview, we discussed the transformative role of cell painting and KI technologies in advancing drug discovery.